This site requires JavaScript to be enabled. Please enable JavaScript in your browser settings, or upgrade to a modern browser.

[TOP STORY] Have you been putting healthcare into your offshore portfolios?

Loading player...

New investors might opt for Pfizer, with its somewhat better metrics and yield, as well as its access to the mRNA technology, says Gary Booysen from Rand Swiss.

23 Jul 2021 4AM English South Africa Business News · Business

Other recent episodes

[TOP STORY] Purple Group growth slows, but Savage optimistic on future prospects

CEO Charles Savage discusses growth strategies amid challenging market conditions. ‘I think active ETFs will displace unit trusts over the next decade or so.’

13 Nov 2AM 9 min

Nvidia: What now?

A look at Nvidia and which South African consumer stocks could benefit from a recovery in discretionary spending. Plus, what upcoming credit rating reviews could mean for SA’s markets.

13 Nov 12AM 22 min

[TOP STORY] Property owners wait for municipal improvements post elections

‘As landlords across the board, we have to think about how we survive with the disruption around us, rather than sitting around and waiting for a solution to happen’: Dipula Properties CEO Izak Peterson.

12 Nov 1AM 6 min

Anthropic’s mega IPO: Buy the hype or sit it out?

Analysis of Anthropic’s potential $1.5trn IPO. Plus, Dipula Properties’s strong results and its exit from residential property.

12 Nov 12AM 19 min

[TOP STORY] Is modern investing as simple as selecting a few stocks or ETFs?

Queen Mahachi from Citadel explains why access to investments isn't the same as financial advice, and where professional advisors add real value.

11 Nov 2AM 6 min

All episodes